Inventor · disambiguated record
Holger Monenschein
Also filed as: MONENSCHEIN HOLGER
44 granted patents·3 pending applications·257 citations·filing 2005–2023
97Inventor score
Files withTAKEDA PHARMACEUTICALS CO20AMGEN INC12ZHONG WENGE4ALLEN JENNIFER R2ENVOY THERAPEUTICS INC2
Top patents by PatentIndex Score
47 records- 0195US7919514B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2008·Granted Apr 5, 2011·42 cites·9 claims
- 0294US7897619B2Heterocyclic modulators of PKBAMGEN INC·Filed 2008·Granted Mar 1, 2011·42 cites·41 claims
- 0394US7700636B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2008·Granted Apr 20, 2010·33 cites·11 claims
- 0494US7354944B2Thiadiazole compounds and methods of useAMGEN INC·Filed 2005·Granted Apr 8, 2008·38 cites·8 claims
- 0592US9556130B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 31, 2017·9 cites·18 claims
- 0691US11173161B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·2 cites·33 claims
- 0791US10159677B24-OXO-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 25, 2018·7 cites·32 claims
- 0890US9770450B24-OXO-3,4-dihydro-1,2,3-benzotriazine as modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·7 cites·32 claims
- 0988US9303045B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Apr 5, 2016·7 cites·11 claims
- 1087US10561662B24-oxo-3,4-dihydro-1,2,3-benzotriazine modulators of GPR139TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 18, 2020·4 cites·32 claims
- 1187US9012447B25-HT3 receptor antagonistsENVOY THERAPEUTICS INC·Filed 2013·Granted Apr 21, 2015·8 cites·15 claims
- 1286US9346829B25-HT3 receptor antagonistsHITCHCOCK STEPHEN·Filed 2015·Granted May 24, 2016·5 cites·2 claims
- 1386US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 1485US9670229B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 6, 2017·3 cites·11 claims
- 1584US9770452B2Quinoxaline derivatives as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Sep 26, 2017·4 cites·22 claims
- 1682US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 1780US9487526B2Quinoxaline derivatives as GPR6 modulatorsENVOY THERAPEUTICS INC·Filed 2013·Granted Nov 8, 2016·5 cites·21 claims
- 1880US9376450B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsAMGEN INC·Filed 2013·Granted Jun 28, 2016·4 cites·26 claims
- 1979US8497265B2Heteroaryloxyheterocyclyl compounds as PDE10 inhibitorsALLEN JENNIFER R·Filed 2011·Granted Jul 30, 2013·4 cites·16 claims
- 2079US8318718B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Nov 27, 2012·4 cites·94 claims
- 2177US10179783B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 15, 2019·2 cites·8 claims
- 2277US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 2375US10077266B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 18, 2018·1 cites·11 claims
- 2472US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 2571US9708313B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsBROWN JASON W·Filed 2015·Granted Jul 18, 2017·1 cites·15 claims
- 2670US9181249B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICAL·Filed 2014·Granted Nov 10, 2015·1 cites·19 claims
- 2770US8778941B2TRPM8 antagonists and their use in treatmentsBROWN JAMES·Filed 2012·Granted Jul 15, 2014·1 cites·33 claims
- 2870US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 2969US10738046B2Substituted pyrido[3,4-b]pyrazines as GPR6 modulatorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 11, 2020·0 cites·21 claims
- 3068US10597392B2Tetrahydropyridopyrazines as modulators of GPR6TAKEDA PHARMACEUTICAL CORPORATION LTD·Filed 2018·Granted Mar 24, 2020·1 cites·11 claims
- 3168US10407443B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·14 claims
- 3268US10000468B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 19, 2018·1 cites·10 claims
- 3365US10125145B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Nov 13, 2018·0 cites·12 claims
- 3463US2025340563A1Fused pyridazine derivatives as nlrp3 inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 3563US2018072758A15ht3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 3662US9695195B25-HT3 receptor antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 4, 2017·0 cites·9 claims
- 3761US10406157B2Tetrahydropyridopyrazine modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 10, 2019·0 cites·28 claims
- 3860US8163909B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 3956US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 4052US2014235642A1Trpm8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Application pending·0 cites
- 4151US10273225B2Pyrazines as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·0 cites·12 claims
- 4249US12370192B2Azole-fused pyridazin-3(2H)-one derivativesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 29, 2025·0 cites·28 claims
- 4349US8759532B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2012·Granted Jun 24, 2014·0 cites·80 claims
- 4446US8552181B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2012·Granted Oct 8, 2013·0 cites·12 claims
- 4543US11426397B2Piperidinyl- and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6TAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 30, 2022·0 cites·17 claims
- 4643US8476297B2TRP-M8 receptor ligands and their use in treatmentsNORMAN MARK H·Filed 2008·Granted Jul 2, 2013·0 cites·11 claims
- 4743US8163766B2Beta-secretase modulators and methods of useZHONG WENGE·Filed 2010·Granted Apr 24, 2012·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Holger Monenschein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →